Want to see HK:0239 full AI Analyst Report?
0239 Stock Chart & Stats
HK$2.38
-HK$0.03(-1.22%)
At close: 4:00 PM EST
HK$2.38
-HK$0.03(-1.22%)
Day’s Range― - ―
52-Week RangeHK$2.24 - HK$2.65
Previous CloseN/A
Volume52.50K
Average Volume (3M)22.62K
Market Cap
HK$741.70M
Enterprise ValueHK$423.54M
Total Cash (Recent Filing)HK$344.54M
Total Debt (Recent Filing)HK$6.87M
Price to Earnings (P/E)7.9
Beta-0.11
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.52%
Share Statistics
EPS (TTM)0.30
Shares Outstanding311,640,000
10 Day Avg. Volume26,750
30 Day Avg. Volume22,616
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.02
Price to Sales (P/S)3.45
P/FCF Ratio6.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage and a conservative balance sheet provide durable financial flexibility: easier access to credit, resilience in downturns, and capacity to fund dividends or opportunistic acquisitions without stressing cash flow. This lowers long-term solvency risk and supports capital allocation optionality.
High Recent ProfitabilitySustained high net margins in 2023–2025 indicate the business converts revenue into earnings efficiently. For a property-investment focused group, stronger margins reflect favorable lease terms, operating discipline or valuation gains, underpinning long-term ability to generate distributable earnings and fund reinvestment.
Robust Cash GenerationConsistent operating and free cash flow through 2023–2025, including a marked FCF step-up in 2025, signals durable cash conversion of reported earnings. Strong cash flow supports shareholder returns, maintenance capex and reduces refinancing risk, providing a stable base for long-term planning.
Bears Say
Top-line VolatilityRepeated revenue declines across recent years demonstrate top-line instability, which can make earnings and cash forecasts less reliable. For a landlord-centric model, fluctuating rental income or timing of property disposals can materially swing operating results and impair predictability of returns over a multi-quarter horizon.
Historic Earnings/cash VolatilityPast periods of weak or negative results (notably 2020–2022) and intermittent cash weakness show the business is cyclically sensitive. This historical volatility increases execution risk during market stress and raises the probability that cash generation and dividends could be pressured in adverse property market cycles.
Concentrated Property Income ModelReliance on a single primary revenue stream—investment property income and valuation changes—means limited diversification. Long-term performance is tied to property market cycles, leasing demand and valuation movements, making earnings and cash sensitive to structural shifts in real estate demand or regulation.
Pak Fah Yeow International Limited News
0239 FAQ
What was Pak Fah Yeow International Limited’s price range in the past 12 months?
Pak Fah Yeow International Limited lowest stock price was HK$2.24 and its highest was HK$2.65 in the past 12 months.
What is Pak Fah Yeow International Limited’s market cap?
Pak Fah Yeow International Limited’s market cap is HK$741.70M.
When is Pak Fah Yeow International Limited’s upcoming earnings report date?
Pak Fah Yeow International Limited’s upcoming earnings report date is Sep 02, 2026 which is in 62 days.
How were Pak Fah Yeow International Limited’s earnings last quarter?
Pak Fah Yeow International Limited released its earnings results on Mar 30, 2026. The company reported HK$0.166 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.166.
Is Pak Fah Yeow International Limited overvalued?
According to Wall Street analysts Pak Fah Yeow International Limited’s price is currently Overvalued.
Does Pak Fah Yeow International Limited pay dividends?
Pak Fah Yeow International Limited pays a Notavailable dividend of HK$0.11 which represents an annual dividend yield of 7.52%. See more information on Pak Fah Yeow International Limited dividends here
What is Pak Fah Yeow International Limited’s EPS estimate?
Pak Fah Yeow International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pak Fah Yeow International Limited have?
Pak Fah Yeow International Limited has 311,640,000 shares outstanding.
What happened to Pak Fah Yeow International Limited’s price movement after its last earnings report?
Pak Fah Yeow International Limited reported an EPS of HK$0.166 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.261%.
Which hedge fund is a major shareholder of Pak Fah Yeow International Limited?
Currently, no hedge funds are holding shares in HK:0239
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pak Fah Yeow International Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.39%
12-Months-Change
Fundamentals
Return on Equity
12.80%
Trailing 12-Months
Asset Growth
-1.78%
Trailing 12-Months
Company Description
Pak Fah Yeow International Limited
Pak Fah Yeow International Limited, operating with its subsidiaries, specializes in the production, promotion, and distribution of healthcare goods under the Hoe Hin brand. Its market reach spans the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and other international territories. The company's operations are categorized into three distinct divisions: Healthcare, Property Investments, and Treasury Investments. Among its key offerings are medicated oils, such as white flower embrocation, along with various ointments and solutions for strain relief, including the floral-scented Fúzai 239 white flower embrocation. Beyond its primary healthcare focus, the firm also commits capital to diverse real estate assets, encompassing commercial, industrial, residential, and car park properties, and additionally provides advertising agency services. This enterprise, established in 1927, maintains its corporate headquarters in Wan Chai, Hong Kong.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Wai Yuen Tong Medicine Holdings Limited
―
JBM (Healthcare) Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
Jacobson Pharma Corporation Limited
―